Citadel Advisors’s OKYO Pharma OKYO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$47.7K Buy
+36,964
New +$55.8K ﹤0.01% 13386
2025
Q4
– Sell
-15,355
Closed -$30.7K – 13673
2025
Q3
$30.7K Buy
+15,355
New +$39.1K ﹤0.01% 12387
2025
Q2
– Sell
-27,404
Closed -$34.8K – 14329
2025
Q1
$34.8K Buy
27,404
+6,675
+32% +$7.98K ﹤0.01% 12671
2024
Q4
$23.8K Buy
20,729
+5,853
+39% +$6.28K ﹤0.01% 13059
2024
Q3
$15.3K Buy
+14,876
New +$17.2K ﹤0.01% 12971
2023
Q4
– Sell
-15,943
Closed -$29.5K – 14946
2023
Q3
$29.5K Buy
+15,943
New +$26.8K ﹤0.01% 12279
2022
Q3
– Sell
-26,864
Closed -$54K – 13306
2022
Q2
$54K Buy
+26,864
New +$60.4K ﹤0.01% 11889

Other funds holding OKYO

Citadel Advisors's OKYO Position: Q3 2026 in Review

Citadel Advisors opened a new position in OKYO Pharma (OKYO) in Q3 2026: 36,964 shares worth $47.7K. The stake represents ﹤0.01% of the portfolio and ranks #13386 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in OKYO as recently as Q3 2025.

Citadel Advisors first reported a position in OKYO in Q2 2022 and has held it in 7 quarters since. The position peaked at $54K in Q2 2022. 19 funds tracked by Wall St. Rank hold OKYO as of Q3 2026.

  • Citadel Advisors held 36,964 shares of OKYO Pharma worth $47.7K as of Q3 2026.
  • OKYO Pharma was a new Citadel Advisors position in Q3 2026.
  • OKYO Pharma made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #13386 holding.
  • Citadel Advisors first reported a position in OKYO Pharma in Q2 2022 and has held it in 7 quarters since.
  • Citadel Advisors's OKYO Pharma position peaked at $54K in Q2 2022.
  • 19 funds tracked by Wall St. Rank held OKYO Pharma as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.